NIH-funded research R01 grant

Understanding gene control in lens development to prevent cataracts

Official title: Transcriptional control of gene expression in the lens

Funded at University of Delaware · NIH-11027252 · Data updated 2026-11-12

This study is looking at how certain proteins, called Mafg and Mafk, help the eye lens develop and stay clear, which could help us understand and find new ways to treat cataracts.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Delaware
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$386,676
NIH project number1R01EY036923-01
Project IDNIH-11027252 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals at risk of developing cataracts, particularly those with a family history of lens developmental defects.

Less likely to help

Patients who already have advanced cataracts or other unrelated eye conditions may not benefit from this research.

What this research studies

This research investigates the role of specific transcription factors, Mafg and Mafk, in the development of the eye lens and their connection to cataract formation. By utilizing a bioinformatics tool called iSyTE, the study aims to identify the proteins and mechanisms that regulate lens transparency and development. The researchers will analyze genetically modified mice to observe how changes in these transcription factors affect lens structure and function, providing insights into potential therapeutic targets for cataracts.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cataracts, potentially improving vision and quality of life for patients.

How similar studies have gone: Previous research has shown promising results in understanding gene regulation in lens development, indicating that this approach could yield valuable insights.

Where this research is happening

  • University of Delaware
    Newark, United States
    Active

Researchers

  • Principal investigator: Lachke, Salil — University of Delaware
  • Study coordinator: Lachke, Salil

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.